The efficacy of temozolomide combined with levetiracetam for glioblastoma (GBM) after surgery: a study protocol for a double-blinded and randomized controlled trial

The efficacy of temozolomide combined with levetiracetam for glioblastoma (GBM) after surgery: a study protocol for a double-blinded and randomized controlled trial

Background: Temozolomide is applied as the standard chemotherapy agent in patients with glioblastoma (GBM) after surgery. However, the benefit of this treatment for patients is limited by the invasive growth of gliomas and drug resistance. There are indications from fundamental experimental and retr...

Full description

Bibliographic Details
Main Authors: Cheng, Y. (Author), Huang, N. (Author), Liu, G. (Author), Mao, J. (Author), Sun, M. (Author), Tao, Y. (Author), Wen, R. (Author), Xie, Z. (Author), Zhang, X. (Author), Zhao, G. (Author)
Format: Article
Language:English
Published: BioMed Central Ltd 2022
Subjects:
Brain Neoplasms
brain tumor
Chemotherapy
Clinical trial
glioblastoma
Glioblastoma
Glioblastoma (GBM)
human
Humans
levetiracetam
Levetiracetam
randomized controlled trial (topic)
Randomized Controlled Trials as Topic
Retrospective Studies
retrospective study
temozolomide
Temozolomide
Temozolomide, Levetiracetam
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items